Skip to content

Development and Validation of Pediatric Narcolepsy Patient Reported Outcomes Scale

Development and Validation of Pediatric Narcolepsy Patient Reported Outcomes Scale (PN-PROS)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05373979
Acronym
PN-PROS
Enrollment
212
Registered
2022-05-13
Start date
2019-04-02
Completion date
2024-05-30
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Narcolepsy, Obstructive Sleep Apnea

Brief summary

The purpose of this study is to test a pediatric narcolepsy patient reported outcomes tool to assess pediatric narcolepsy symptoms and their effect on daily functioning and quality of life. The goal is to develop a clinical survey that can improve the care of pediatric narcolepsy.

Detailed description

WHO IS ELIGIBLE? * Children and adolescents with narcolepsy between the ages of 9-17 years * Diagnosis must be verified by a signed letter from physician in order to participate * Participants must be able to understand the purpose of the study PARTICIPATION DETAILS * Upon enrollment participants will receive an email containing a link to complete HIPAA compliant online surveys about narcolepsy symptoms, quality of life, and daily function. Surveys should take no more than 30 minutes. * One week later, some participants will receive another email with a link to complete a 10-minute follow up survey

Interventions

None listed

Sponsors

National Jewish Health
CollaboratorOTHER
Geisinger Clinic
CollaboratorOTHER
The Hospital for Sick Children
CollaboratorOTHER
Stanford University
CollaboratorOTHER
Boston Children's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
9 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Children and adolescents ages 9-17 * Have a diagnosis of narcolepsy type 1, narcolepsy type 2, or mild to moderate obstructive sleep apnea (OSA)

Exclusion criteria

* A history of visual or hearing impairment * A co-morbid neurodevelopmental disorder such as autism or schizophrenia * No access to computer/tablet/smart phone to complete questionnaires

Design outcomes

Primary

MeasureTime frameDescription
Survey Validation2 YearsTo evaluate the content validity and reliability of the PN-PROs item pools through a field test of the item pools in a diverse, national sample of pediatric narcolepsy patients with a comparator group of pediatric mild obstructive sleep apnea patients (9-17 years).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026